Cogent Biosciences financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

코젠트 바이오사이언시스NASDAQ:COGT · Nasdaq · Healthcare

$31.02-1.80%

2026-10-02 close

Cogent Biosciences's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$276M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy